CDC73 and parathyroid gland carcinoma: The aggressive and recurrent behavior of the parathyroid carcinoma is consistent with observations that indicate that the presence of a CDC73 mutation and loss of parafibromin immunostaining predicts significantly higher recurrence rates and lower overall 10-year survival (17).